Natus Medical Incorporated (NASDAQ:BABY) produced a 10.52% rally since recording the worst price of $28.05. Thanks to the latest 6.71% increase, it now trades at $31. Throughout the trading on 01/24/2018, the share price floated between $29 and $31.5. This company shares are 58.06% off its target price of $49 and the current market capitalization stands at $976.19M. The recent change has given its price a -15.91% deficit over SMA 50 and -28.9% deficit over its 52-week high. The stock witnessed -20.21% declines, -22.89% declines and -19.38% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found BABY’s volatility during a week at 3.53% and during a month it has been found around 3.39%.Natus Medical Incorporated (BABY) Top Holders
Institutional investors currently hold around $903 million or 0% in BABY stock. Look at its top three institutional owners. Blackrock Inc. owns $121.43 million in Natus Medical Incorporated, which represents roughly 12.44% of the company’s market cap and approximately 13.45% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 2,373,135 shares of the stock are valued at $68.94 million. The third largest holder is Wellington Management Group Llp, which currently holds $65.3 million worth of this stock and that ownership represents nearly 6.69% of its market capitalization.
At the end of 09/30/2017 reporting period, 83 institutional holders increased their position in Natus Medical Incorporated (NASDAQ:BABY) by some 3,877,429 shares, 114 decreased positions by 4,124,088 and 33 held positions by 23,098,487. That puts total institutional holdings at 31,100,004 shares, according to SEC filings. The stock grabbed 17 new institutional investments totaling 2,252,807 shares while 32 institutional investors sold out their entire positions totaling 920,925 shares.Natus Medical Incorporated (NASDAQ:BABY) Insider Trades
Multiple company employees have indulged in significant insider trading. Natus Medical Incorporated disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Moore William M has sold 5,000 shares of Natus Medical Incorporated (BABY) in trading session dated Nov. 13, 2017. These shares are worth $205,050 and were traded at $41.01 each. The SEC filing shows that Chung Dong Chune Christopher performed a sale of 12,642 shares. The Vice President Medical Affairs disposed these shares by way of transaction on Nov. 06, 2017. The company’s shares were given away at $42.91 per share worth to an income of some $542,468 on account of Chung Dong Chune Christopher.
Director, Gunst Robert A, sold 4,400 common shares of Natus Medical Incorporated (BABY) in the open market. In a transaction dated Sep. 14, 2017, the shares were put up for sale at an average price of $35.17, raking in a sum of $154,748. After this sale, 50,850 common shares of BABY are directly owned by the insider, with total stake valued at $1,576,350.
In the transaction dated Aug. 14, 2017, the great number of shares disposed came courtesy the Director; Moore William M disposed a total of 3,000 shares at an average price of $34.1, amounting to approximately $102,300. The insider now directly owns 128,962 shares worth $3,997,822.Natus Medical Incorporated (BABY) Analyst Guide
Several analysts have released their opinion on Natus Medical Incorporated (NASDAQ:BABY), with 1 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 0 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.